← FDA Drug Approvals (Drugs@FDA)

SARCLISA ESCENA

BLA · Biologics License Application · Sponsor: SANOFI-AVENTIS U.S. LLC · Approved 2026-07-09

Drug application

FDA Application #
BLA761445
Application type
Biologics License Application
Brand name
SARCLISA ESCENA
Generic name
ISATUXIMAB-IRFC
Active ingredients
ISATUXIMAB-IRFC
Dosage form
VIAL
Route
SINGLE-DOSE
Marketing status
Prescription
Sponsor
SANOFI-AVENTIS U.S. LLC
Manufacturer
Sanofi-Aventis U.S. LLC
First approval
2026-07-09

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown